Systemic JIA: new developments in the understanding of the pathophysiology and therapy
- 23 October 2009
- journal article
- review article
- Published by Elsevier
- Vol. 23 (5) , 655-664
- https://doi.org/10.1016/j.berh.2009.08.003
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Subtype‐specific peripheral blood gene expression profiles in recent‐onset juvenile idiopathic arthritisArthritis & Rheumatism, 2009
- Potential Role of Interleukin-18 in the Immunopathogenesis of AIDS: Involvement in Fratricidal Killing of NK CellsJournal of Virology, 2009
- S100A12 is a novel molecular marker differentiating systemic‐onset juvenile idiopathic arthritis from other causes of fever of unknown originArthritis & Rheumatism, 2008
- Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13‐4 polymorphismsArthritis & Rheumatism, 2008
- A pilot study to evaluate the safety and efficacy of the long‐acting interleukin‐1 inhibitor rilonacept (interleukin‐1 trap) in patients with familial cold autoinflammatory syndromeArthritis & Rheumatism, 2008
- Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockadeThe Journal of Experimental Medicine, 2007
- Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional studyAnnals of the Rheumatic Diseases, 2007
- Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhoodThe Journal of Pediatrics, 2006
- Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter studyThe Journal of Pediatrics, 2004
- Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: Possible relationship to drugs or infectionThe Journal of Pediatrics, 1985